Dr. Michael L Johnson, MD Dermatology Medicare: Medicare Enrolled Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
Dr. Cynthia C Lucy, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
Dr. Robert D Griffith, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
Dr. Charles E Gambla, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
Dr. Jeffery C Weeks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
Dr. Karen Dietrich Walker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
Dr. David B Jackson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
Dr. Adam Richardson, DO, FAAD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-332-3714 |
Catherine T. Lucas, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4410 Watermelon Rd, Northport, AL 35473 Phone: 205-345-1520 Fax: 205-345-1761 |
News Archive
As the House and Senate work to merge their health care reform bills, the Health Coalition on Liability and Access (HCLA) sent a letter to House Speaker Nancy Pelosi and Senate Majority Leader Harry Reid, emphasizing the need to retain and strengthen current medical liability reform provisions in any final legislation.
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Previous studies have shown an association between high folic acid intake and a reduction in the immune system defenses needed to fight viral infections and cancer. In a new study in mice published in the Journal of Nutritional Biochemistry, scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University set out to determine if excess folic acid intake caused adverse changes in the immune system.
Mirna Therapeutics announced today publication of new results in the journal Cancer Research demonstrating proof of concept that the systemic delivery of tumor suppressor microRNAs (miRNA) inhibits tumor growth by restoring the proper regulatory pathways required for cell cycle arrest and apoptosis.
› Verified 3 days ago